Merck's anacetrapib has curiously strong effect on lipids
November 18 2010
Researchers said a new kind of cholesterol-modifying drug from Merck demonstrated remarkably strong LDL-lowering and HDL-raising effects, and appeared safe ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.